Sotac Pharmaceuticals Limited engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India. Its therapeutic product portfolio includes anti-diabetic, anti-psychotic, vitamins, minerals, iron, anti-cold, anti-allergic, dermatological products, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics IP-lactams and non-IP-lactams, anti-fungal, and cephalosporin. The company also offers beta and non-beta-lactam tablets; beta and non-beta-lactam capsules; oral liquids; dry syrups; and external preparations, such as nasal sprays, relief sprays, and creams. In addition, it is involved in the research of pharmaceutical molecules used in developing new pharmaceutical formulations; and manufacture of nutraceuticals medicinal and food products. The company also exports its products. Sotac Pharmaceuticals Limited was founded in 2014 and is based in Ahmedabad, India.
Metrics to compare | SOTA | Peers Peers - average of corresponding metrics from companies closely matching SOTA: LINCOLN, MOREPENLAB, KOPRAN, 540694, 524790 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSOTAPeersSector |
---|---|---|---|---|
P/E Ratio | 31.0x | 19.4x | −0.5x | |
PEG Ratio | - | 0.71 | 0.00 | |
Price/Book | 2.9x | 3.3x | 2.6x | |
Price / LTM Sales | 1.3x | 2.6x | 2.9x | |
Upside (Analyst Target) | - | 16.1% | 50.4% | |
Fair Value Upside | Unlock | 0.6% | 9.1% | Unlock |